By A Mystery Man Writer
Merck aims to gradually return to growth in 2024 -March 07, 2024 at 02:58 am EST
investment CHEManager
Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth
Merck CHEManager
We are Merck
One of the largest private investment rounds in European biotech to-date - ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities
BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
Wacker Expands Capacity for Specialty Silicones in China
Merck opens new EUR 20 million distribution center in Brazil - Premium Beauty News